JP2013014622A5 - - Google Patents

Download PDF

Info

Publication number
JP2013014622A5
JP2013014622A5 JP2012230565A JP2012230565A JP2013014622A5 JP 2013014622 A5 JP2013014622 A5 JP 2013014622A5 JP 2012230565 A JP2012230565 A JP 2012230565A JP 2012230565 A JP2012230565 A JP 2012230565A JP 2013014622 A5 JP2013014622 A5 JP 2013014622A5
Authority
JP
Japan
Prior art keywords
solvate
pharmaceutically acceptable
acceptable salt
compound
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012230565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013014622A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013014622A publication Critical patent/JP2013014622A/ja
Publication of JP2013014622A5 publication Critical patent/JP2013014622A5/ja
Pending legal-status Critical Current

Links

JP2012230565A 2007-03-15 2012-10-18 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 Pending JP2013014622A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91817107P 2007-03-15 2007-03-15
US60/918,171 2007-03-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009553612A Division JP5147866B2 (ja) 2007-03-15 2008-03-12 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013259117A Division JP2014051529A (ja) 2007-03-15 2013-12-16 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Publications (2)

Publication Number Publication Date
JP2013014622A JP2013014622A (ja) 2013-01-24
JP2013014622A5 true JP2013014622A5 (enExample) 2014-02-06

Family

ID=39525788

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009553612A Expired - Fee Related JP5147866B2 (ja) 2007-03-15 2008-03-12 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体
JP2012230565A Pending JP2013014622A (ja) 2007-03-15 2012-10-18 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体
JP2013259117A Pending JP2014051529A (ja) 2007-03-15 2013-12-16 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009553612A Expired - Fee Related JP5147866B2 (ja) 2007-03-15 2008-03-12 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013259117A Pending JP2014051529A (ja) 2007-03-15 2013-12-16 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Country Status (18)

Country Link
US (1) US8232274B2 (enExample)
EP (2) EP2586778A3 (enExample)
JP (3) JP5147866B2 (enExample)
KR (1) KR20100049500A (enExample)
CN (1) CN101730692A (enExample)
AR (1) AR065721A1 (enExample)
AU (1) AU2008227100B2 (enExample)
BR (1) BRPI0809238A2 (enExample)
CA (1) CA2680583A1 (enExample)
CL (1) CL2008000725A1 (enExample)
CO (1) CO6220966A2 (enExample)
EC (1) ECSP099634A (enExample)
IL (1) IL200906A0 (enExample)
MX (1) MX2009009948A (enExample)
PE (1) PE20081882A1 (enExample)
RU (1) RU2009137946A (enExample)
TW (1) TW200902516A (enExample)
WO (1) WO2008115381A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8536168B2 (en) 2007-03-15 2013-09-17 Novartis Ag Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway
MX2009009849A (es) * 2007-03-15 2009-09-24 Schering Corp Derivados de piridazinona sustituida con piperazina utiles como inhibidores de glucano sintasa.
ES2499018T3 (es) * 2007-09-20 2014-09-26 Irm Llc Compuestos y composiciones como moduladores de la actividad de GPR119
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
US20120088769A1 (en) * 2010-10-11 2012-04-12 Axikin Pharmaceuticals, Inc. Salts of arylsulfonamide ccr3 antagonists
FI20115234A0 (fi) 2011-03-08 2011-03-08 Biotie Therapies Corp Uusia pyridatsinoni- ja pyridoniyhdisteitä
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
AP2014007637A0 (en) 2011-11-15 2014-05-31 Takeda Pharmaceutical Dihydroxy aromatic heterocyclic compound
WO2013155223A1 (en) * 2012-04-10 2013-10-17 The Regents Of The University Of California Compositions and methods for treating cancer
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
CN103664795B (zh) * 2012-09-06 2017-10-03 华东理工大学 哒嗪酮类化合物及其用途
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN104717924A (zh) 2012-10-05 2015-06-17 皇家飞利浦有限公司 用于提供增强的x射线图像的医学成像系统及方法
GB201222711D0 (en) * 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
WO2015031036A1 (en) * 2013-08-26 2015-03-05 Purdue Pharma L.P. Azaspiro[4.5] decane derivatives and use thereof
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
AU2015251501B2 (en) * 2014-04-24 2019-08-15 Hexima Limited Agents and methods of treatment
WO2017155879A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3596043B1 (en) * 2017-03-15 2025-12-03 Lunella Biotech, Inc. Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast
WO2018185013A1 (en) 2017-04-03 2018-10-11 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
US12435078B2 (en) 2017-09-18 2025-10-07 Gfb (Abc), Llc Pyridazinones and methods of use thereof
CN109912476A (zh) * 2019-03-27 2019-06-21 南通宝凯化工有限公司 一种异丙氨基磺酰氯的生产工艺
CN112469713B (zh) * 2019-06-21 2023-09-01 江苏豪森药业集团有限公司 芳基磷氧化物类衍生物抑制剂、其制备方法和应用
WO2021113625A1 (en) * 2019-12-06 2021-06-10 Plexxikon Inc. Compounds and methods for cd73 modulation and indications therefor
MX2022013615A (es) 2020-04-30 2022-11-16 Gilead Sciences Inc Inhibidores de macrociclo de peptidilarginina deiminasas.
WO2023204124A1 (ja) * 2022-04-20 2023-10-26 日本曹達株式会社 ピリダジノン化合物並びに農園芸用殺菌剤、殺線虫剤、および医療用・動物用抗真菌剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS565734B2 (enExample) * 1973-02-28 1981-02-06
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
ES8601972A1 (es) 1985-02-28 1985-11-16 Abello Quimicos Farma Prod Sa Procedimiento de obtencion de 1,2-diazin-3 (2h)-onas con interes farmaceutico
JPH04235975A (ja) * 1991-01-21 1992-08-25 Nissan Chem Ind Ltd ピリダジノン誘導体および害虫防除剤
GB2256587A (en) 1991-06-11 1992-12-16 American Cyanamid Co Acetazolamide in sustained release form
HU227237B1 (en) * 2001-09-27 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them
CA2474850A1 (en) * 2002-01-31 2003-08-07 Daiichi Pharmaceutical Co., Ltd. Imidazo[1,2-a]pyridine derivatives
DE10216144A1 (de) * 2002-04-12 2003-11-06 Bayer Ag Substituierte 2-Phenyl-3(2H)-Pyridazinone
US20050209278A1 (en) * 2002-04-25 2005-09-22 Mcdonald Joseph J Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
KR101190912B1 (ko) * 2003-11-19 2012-10-12 어레이 바이오파마 인크. Mek의 헤테로시클릭 억제제 및 그의 사용 방법
WO2005117909A2 (en) * 2004-04-23 2005-12-15 Exelixis, Inc. Kinase modulators and methods of use
GB0524991D0 (en) * 2005-12-08 2006-01-18 Ge Healthcare Ltd Novel imaging agents for fibrosis
WO2007130383A2 (en) * 2006-04-28 2007-11-15 Northwestern University Compositions and treatments using pyridazine compounds and secretases
MX2009009849A (es) * 2007-03-15 2009-09-24 Schering Corp Derivados de piridazinona sustituida con piperazina utiles como inhibidores de glucano sintasa.

Similar Documents

Publication Publication Date Title
JP2014507446A5 (enExample)
JP2012107057A5 (enExample)
JP2012126725A5 (enExample)
JP2017509667A5 (enExample)
JP2014221779A5 (enExample)
JP2011105738A5 (enExample)
EP2833721A4 (en) NICKEL OXIDE RELEASING PHARMACEUTICAL COMPOSITIONS
HRP20250119T1 (hr) Kdm1a inhibitor i njegova primjena u terapiji
JP2015525757A5 (enExample)
JP2013525444A5 (enExample)
JP2015501783A5 (enExample)
ZA201501977B (en) Orally administered medical composition
JP2012143233A5 (enExample)
JP2013532687A5 (enExample)
JP2012255026A5 (enExample)
JP2011006431A5 (enExample)
JP2013509429A5 (enExample)
JP2013520167A5 (enExample)
JP2016535100A5 (enExample)
JP2014530840A5 (enExample)
JP2019516735A5 (enExample)
TWI559929B (en) Pharmaceutical composition for use in the treatment of a neurodegenerative disease
JP2016500312A5 (enExample)
PL3003285T3 (pl) Stała farmaceutyczna postać dawkowania do uwalniania co najmniej dwóch substancji czynnych w jamie ustnej
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease